Ypsomed Holding AG (LTS:0QLQ) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QLQ Ypsomed Holding AG LTS:0QLQ
86 GF Score
Price CHF350.40
GF Value CHF393.96
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ypsomed Holding AG Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Ypsomed Holding AG  (LTS:0QLQ) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Ypsomed Holding AG Cyclically Adjusted PS Ratio Related Terms


Ypsomed Holding AG Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Ypsomed Holding AG's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ypsomed Holding AG Cyclically Adjusted PS Ratio Chart

Ypsomed Holding AG Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.39 5.88 10.37 8.99 6.84

Ypsomed Holding AG Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.34 11.44 8.96 7.97 6.82

LTS:0QLQ vs ISRG, BDX, RMD: Cyclically Adjusted PS Ratio Comparison

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Cyclically Adjusted PS Ratio falls into.


LTS:0QLQ
86GF Score
Ypsomed Holding AG LTS:0QLQ
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ypsomed Holding AG Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Ypsomed Holding AG's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Mar26 is calculated as:

For example, Ypsomed Holding AG's adjusted Revenue per Share data for the fiscal year that ended in Mar26 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar26 (Change)*Current CPI (Mar26)
=53.686/108.0600*108.0600
=53.686

Current CPI (Mar26) = 108.0600.

Ypsomed Holding AG Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201703 30.788 100.040 33.256
201803 36.919 100.836 39.564
201903 35.894 101.571 38.187
202003 31.187 101.048 33.351
202103 31.907 100.800 34.205
202203 36.648 103.205 38.372
202303 37.072 106.245 37.705
202403 40.175 107.355 40.439
202503 54.847 107.722 55.019
202603 53.686 108.060 53.686

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Ypsomed Holding AG (LTS:0QLQ) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of CHF350.40 is trading 11.1% below its estimated GF Value™ of CHF393.96. GuruFocus considers Ypsomed Holding AG to be Modestly Undervalued.

Key valuation signals for LTS:0QLQ:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: CHF393.96 vs. price of CHF350.40 (11.1% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the LTS:0QLQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ypsomed Holding AG Business Description

Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
86GF Score

Get the complete analysis for LTS:0QLQ

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF350.40
Price
CHF393.96
GF Value